This site uses cookies, including third-party cookies, that help us to provide and improve our services. Read More

Respiratory Virus Vaccines Market

Respiratory Virus Vaccines Market

Respiratory Virus Vaccines Market By Type (Inactivated/Killed, Live-attenuated, Recombinant), Route of Administration (Intramuscular, Intranasal, Subcutaneous), By Age Group, By Region - Global Market Forecast 2020-2030

Respiratory Virus Vaccines Market
FACT5199MR
  • Mar-2022
  • List of Tables : 43
  • List of Figures : 95
  • 170 Pages
  • Healthcare

Table of Content

1. Executive Summary

    1.1. Summary of Key Findings

    1.2. Summary of Statistics 

    1.3. Fact.MR Analysis and Recommendations

2. Market Overview

    2.1. Market Introduction

    2.2. Market Definition 

    2.3. Market Taxonomy

3. Market Risks & Trends Assessment

    3.1. COVID-19 Impact Benchmark with Previous Crisis  

        3.1.1. Change in Respiratory Virus Vaccines Demand and Consumption Growth

        3.1.2. Before and After COVID-19 Crisis (Projected)

        3.1.3. Before and after SARS Pandemic (Actual)

        3.1.4. Before and After Sub-prime Crisis – 2008 (Actual)

        3.1.5. Change in Demand post Recovery Period (After Each Crisis)

    3.2. Impact on Market Value (US$ Mn)

        3.2.1. Likely Loss of Value in 2020

        3.2.2. Mid-term and Long Term Forecast

        3.2.3. Quarter by Quarter Dip and Recovery Assessment 

    3.3. Anticipated Demand and Value Recovery Curve

        3.3.1. Likelihood of U-Shape Recovery

        3.3.2. Likelihood of L-Shape Recovery

    3.4. Recovery Period Assessment by Key Countries

4. Market Background and Associated Industry Indicators

    4.1. Global Pharmaceutical Industry Outlook

        4.1.1. Key Trends in Pharmaceutical Market

        4.1.2. Pharmaceutical Market, by Region

        4.1.3. Pharmaceutical Market, by Competition

    4.2. Global Healthcare Industry Outlook

        4.2.1. Key trends in Healthcare Industry

    4.3. Healthcare Industry, by Region

    4.4. Forecast Factors - Relevance & Impact for Respiratory Virus Vaccines

        4.4.1. Key Market Players Historic Growth

        4.4.2. Pharmaceutical Industry Growth Outlook

        4.4.3. Others

    4.5. Value Chain Analysis and Operating Margins 

        4.5.1. List of Raw Material Suppliers

        4.5.2. List of Key Manufacturers

        4.5.3. List of End-users

        4.5.4. Profit Margins 

        4.5.5. Notes on Value Added at Each Node in the Value Chain

    4.6. Market Dynamics

        4.6.1.  Drivers

        4.6.2. Restraints and Market Risks

        4.6.3. Opportunity Analysis

5. Global Respiratory Virus Vaccines Market Demand Analysis 2015-2019 and Forecast, 2020-2030

    5.1.  Historical Market   Analysis, 2015-2019

    5.2.  Current and Future Market   Projections, 2020-2030

        5.2.1. Y-o-Y Growth Trend Analysis

        5.2.2. Absolute $ Opportunity Analysis

6. Global Respiratory Virus Vaccines Market - Pricing Analysis

    6.1. Regional Pricing Analysis 

    6.2. Pricing Break-up

    6.3. Global Average Pricing Analysis Benchmark

7. Global Respiratory Virus Vaccines Market Demand (in US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

    7.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

    7.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Respiratory Virus Vaccines Market Analysis 2015-2019 and Forecast 2020-2030, By Type

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) and Analysis by Type, 2015 - 2019

    8.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast by Type, 2020 - 2030

        8.3.1. Inactivated/Killed Vaccines

        8.3.2. Live-attenuated Vaccines

        8.3.3. Recombinant Vaccines

    8.4. Market Attractiveness Analysis by Type

9. Global Respiratory Virus Vaccines Market Analysis 2015-2019 and Forecast 2020-2030, By Route of Administration

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) and Analysis by Route of Administration, 2015 - 2019

    9.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast by Route of Administration, 2020 - 2030

        9.3.1. Intramuscular

        9.3.2. Intranasal

        9.3.3. Subcutaneous

10. Global Respiratory Virus Vaccines Market Analysis 2015-2019 and Forecast 2020-2030, By Indication

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) and Analysis by Route of Administration, 2015 - 2019

    10.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast by Indication, 2020 - 2030

        10.3.1. Influenza

        10.3.2. Measles, Mumps & Rubella

        10.3.3. Coronavirus Disease (COVID-19)

11. Global Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Age Group

    11.1. Global Respiratory Virus Vaccines Market Value Forecast, by Age Group, 2018–2030

        11.1.1. Pediatric 

        11.1.2. Adults

12. Global Respiratory Virus Vaccines Market Attractiveness Analysis, by Age Group

13. Global Respiratory Virus Vaccines Market Analysis 2015-2019 and Forecast 2020-2030, By End user

    13.1. Introduction / Key Findings

    13.2. Historical Market Size (US$ Mn) and Analysis by End-user, 2015 - 2019

    13.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast by End-user, 2020 - 2030

        13.3.1. Physician’s Office

        13.3.2. Hospitals

        13.3.3. Clinics

        13.3.4. Pharmacies/Stores

14. Global Respiratory Virus Vaccines Market Analysis 2015-2019 and Forecast 2020-2030, By Region 

    14.1. Introduction / Key Findings

    14.2. Historical Market Size (US$ Mn) and  Analysis By Region, 2015 - 2019

    14.3. Current and Future Market Size (US$ Mn) and  Analysis and Forecast By Region, 2018 – 2028

        14.3.1. North America

        14.3.2. Latin America 

        14.3.3. Europe

        14.3.4. Asia Pacific

        14.3.5. Middle East & Africa 

15. North America Respiratory Virus Vaccines Market Analysis 2015-2019 and Forecast 2020-2030

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Size (US$ Mn) and  Trend Analysis By Market Taxonomy, 2015 - 2019

    15.4. Market Size (US$ Mn) and  Forecast By Market Taxonomy, 2020 - 2030

        15.4.1. By Country

        15.4.2. U.S.

        15.4.3. Canada

        15.4.4. By Type 

        15.4.5. By Route of Administration

        15.4.6. By Indication

        15.4.7. By Age Group

        15.4.8. By End User

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Type 

        15.5.3. By Route of Administration

        15.5.4. By Indication

        15.5.5. By Age Group

        15.5.6. By End User

    15.6. Market Trends

    15.7. Key Market Participants - Intensity Mapping

    15.8. Drivers and Restraints - Impact Analysis

16. Latin America Respiratory Virus Vaccines Market Analysis 2015-2019 and Forecast 2020-2030

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Size (US$ Mn) and Trend Analysis by Market Taxonomy, 2015 - 2019

    16.4. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2020 - 2030

        16.4.1. By Country

        16.4.2. Brazil

        16.4.3. Mexico

        16.4.4. Rest of Latin America

        16.4.5. By Type 

        16.4.6. By Route of Administration

        16.4.7. By Indication

        16.4.8. By Age Group

        16.4.9. By End-user

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Type 

        16.5.3. By Route of Administration 

        16.5.4. By Indication

        16.5.5. By Age Group

        16.5.6. By End-user

    16.6. Market Trends

    16.7. Key Market Participants - Intensity Mapping

    16.8. Drivers and Restraints - Impact Analysis

17. Europe Respiratory Virus Vaccines Market Analysis 2015-2019 and Forecast 2020-2030

    17.1. Introduction

    17.2. Pricing Analysis

    17.3. Historical Market Size (US$ Mn) and  Trend Analysis By Market Taxonomy, 2015 - 2019

    17.4. Market Size (US$ Mn) and  Forecast By Market Taxonomy, 2020 - 2030

        17.4.1. By Country

        17.4.2. Germany

        17.4.3. Italy

        17.4.4. France

        17.4.5. U.K.

        17.4.6. Spain

        17.4.7. Russia

        17.4.8. Poland

        17.4.9. Rest of Europe

        17.4.10. By Type 

        17.4.11. By Route of Administration

        17.4.12. By Indication

        17.4.13. By Age Group

        17.4.14. By End-user

    17.5. Market Attractiveness Analysis

        17.5.1. By Country

        17.5.2. By Type 

        17.5.3. By Route of Administration

        17.5.4. By Indication

        17.5.5. By Age Group

        17.5.6. By End-user

    17.6. Market Trends

    17.7. Key Market Participants - Intensity Mapping

    17.8. Drivers and Restraints - Impact Analysis

18. Asia Pacific Respiratory Virus Vaccines Market Analysis 2015-2019 and Forecast 2020-2030

    18.1. Introduction

    18.2. Pricing Analysis

    18.3. Historical Market Size (US$ Mn) and  Trend Analysis By Market Taxonomy, 2015 - 2019

    18.4. Market Size (US$ Mn) and  Forecast By Market Taxonomy, 2020 - 2030

        18.4.1. By Country

        18.4.2. China

        18.4.3. South Korea

        18.4.4. By Type 

        18.4.5. By Route of Administration

        18.4.6. By Indication

        18.4.7. By Age Group

        18.4.8. By End-user

    18.5. Market Attractiveness Analysis

        18.5.1. By Country

        18.5.2. By Type 

        18.5.3. By Route of Administration

        18.5.4. By Indication

        18.5.5. By Age Group

        18.5.6. By End-user

    18.6. Market Trends

    18.7. Key Market Participants - Intensity Mapping

    18.8. Drivers and Restraints - Impact Analysis

19. Middle East and Africa Respiratory Virus Vaccines Market Analysis 2015-2019 and Forecast 2020-2030

    19.1. Introduction

    19.2. Pricing Analysis

    19.3. Historical Market Size (US$ Mn) and  Trend Analysis By Market Taxonomy, 2015 - 2019

    19.4. Market Size (US$ Mn) and  Forecast By Market Taxonomy, 2020 - 2030

        19.4.1. By Country

        19.4.2. GCC Countries

        19.4.3. Israel

        19.4.4. South Africa

        19.4.5. Rest of Middle East and Africa

        19.4.6. By Country

        19.4.7. By Type 

        19.4.8. By Route of Administration

        19.4.9. By Indication

        19.4.10. By Age Group

        19.4.11. By End-user

    19.5. Market Attractiveness Analysis

        19.5.1. By Country

        19.5.2. By Type 

        19.5.3. By Route of Administration

        19.5.4. By Indication

        19.5.5. By Age Group

        19.5.6. By End-user

    19.6. Market Trends

    19.7. Key Market Participants - Intensity Mapping

    19.8. Drivers and Restraints - Impact Analysis

20. Key Countries Respiratory Virus Vaccines Market Analysis 2015-2019 and Forecast 2020-2030

    20.1. Introduction

        20.1.1. Market Value Proportion Analysis, By Key Countries

        20.1.2. Global Vs. Country Growth Comparison

    20.2. U.S. Respiratory Virus Vaccines Market Analysis

        20.2.1. Pricing Analysis

        20.2.2. Market Value Proportion Analysis by Market Taxonomy

        20.2.3. Market Value (US$ Mn) and  Analysis and Forecast by Market Taxonomy

        20.2.4. By Type 

        20.2.5. By Route of Administration

        20.2.6. By Indication

        20.2.7. By Age Group

        20.2.8. By End-user

    20.3. Canada Respiratory Virus Vaccines Market Analysis

        20.3.1. Pricing Analysis

        20.3.2. Market Value Proportion Analysis by Market Taxonomy

        20.3.3. Market Value (US$ Mn) and  Analysis and Forecast by Market Taxonomy

        20.3.4. By Type 

        20.3.5. By Route of Administration

        20.3.6. By Indication

        20.3.7. By Age Group

        20.3.8. By End-user

    20.4. Germany Respiratory Virus Vaccines Market Analysis

        20.4.1. Pricing Analysis

        20.4.2. Market Value Proportion Analysis by Market Taxonomy

        20.4.3. Market Value (US$ Mn) and  Analysis and Forecast by Market Taxonomy

        20.4.4. By Type 

        20.4.5. By Route of Administration

        20.4.6. By Indication

        20.4.7. By Age Group

        20.4.8. By End-user

    20.5. France Respiratory Virus Vaccines Market Analysis

        20.5.1. Pricing Analysis

        20.5.2. Market Value Proportion Analysis by Market Taxonomy

        20.5.3. Market Value (US$ Mn) and  Analysis and Forecast by Market Taxonomy

        20.5.4. By Type 

        20.5.5. By Route of Administration

        20.5.6. By Indication

        20.5.7. By Age Group

        20.5.8. By End-user

    20.6. UK Respiratory Virus Vaccines Market Analysis

        20.6.1. Pricing Analysis

        20.6.2. Market Value Proportion Analysis by Market Taxonomy

        20.6.3. Market Value (US$ Mn) and  Analysis and Forecast by Market Taxonomy

        20.6.4. By Type 

        20.6.5. By Route of Administration

        20.6.6. By Indication

        20.6.7. By Age Group

        20.6.8. By End-user

        20.6.9. BENELUX Respiratory Virus Vaccines Market Analysis

        20.6.10. Pricing Analysis

        20.6.11. Market Value Proportion Analysis by Market Taxonomy

        20.6.12. Market Value (US$ Mn) and  Analysis and Forecast by Market Taxonomy

        20.6.13. By Type 

        20.6.14. By Route of Administration

        20.6.15. By Indication

        20.6.16. By Age Group

        20.6.17. By End-user

        20.6.18. Russia Respiratory Virus Vaccines Market Analysis

        20.6.19. Pricing Analysis

        20.6.20. Market Value Proportion Analysis by Market Taxonomy

        20.6.21. Market Value (US$ Mn) and  Analysis and Forecast by Market Taxonomy

        20.6.22. By Type 

        20.6.23. By Route of Administration

        20.6.24. By Indication

        20.6.25. By Age Group

        20.6.26. By End-user

        20.6.27. India Respiratory Virus Vaccines Market Analysis

        20.6.28. Pricing Analysis

        20.6.29. Market Value Proportion Analysis by Market Taxonomy

        20.6.30. Market Value (US$ Mn) and  Analysis and Forecast by Market Taxonomy

        20.6.31. By Type 

        20.6.32. By Route of Administration

        20.6.33. By Indication

        20.6.34. By Age Group

        20.6.35. By End-user

        20.6.36. Malaysia Respiratory Virus Vaccines Market Analysis

        20.6.37. Pricing Analysis

        20.6.38. Market Value Proportion Analysis by Market Taxonomy

        20.6.39. Market Value (US$ Mn) and  Analysis and Forecast by Market Taxonomy

        20.6.40. By Type 

        20.6.41. By Route of Administration

        20.6.42. By Indication

        20.6.43. By Age Group

        20.6.44. By End-user

        20.6.45. China Respiratory Virus Vaccines Market Analysis

        20.6.46. Pricing Analysis

        20.6.47. Market Value Proportion Analysis by Market Taxonomy

        20.6.48. Market Value (US$ Mn) and Analysis and Forecast by Market Taxonomy

        20.6.49. By Type 

        20.6.50. By Route of Administration

        20.6.51. By Indication

        20.6.52. By Age Group

        20.6.53. By End-user

        20.6.54. Poland Respiratory Virus Vaccines Market Analysis

        20.6.55. Pricing Analysis

        20.6.56. Market Value Proportion Analysis by Market Taxonomy

        20.6.57. Market Value (US$ Mn) and Analysis and Forecast by Market Taxonomy

        20.6.58. By Type 

        20.6.59. By Route of Administration

        20.6.60. By Indication

        20.6.61. By Age Group

        20.6.62. By End-user

        20.6.63. South Korea Respiratory Virus Vaccines Market Analysis

        20.6.64. Pricing Analysis

        20.6.65. Market Value Proportion Analysis by Market Taxonomy

        20.6.66. Market Value (US$ Mn) and Analysis and Forecast by Market Taxonomy

        20.6.67. By Type 

        20.6.68. By Route of Administration

        20.6.69. By Indication

        20.6.70. By Age Group

        20.6.71. By End-user

21. Market Structure Analysis

    21.1. Market Analysis by Tier of Companies (Respiratory Virus Vaccines)

    21.2. Market Concentration

    21.3. Market Share Analysis of Top Players

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Competition Benchmarking

    22.3. Competition Deep Dive 

        22.3.1. CSL Limited

            22.3.1.1. Overview

            22.3.1.2. Product Portfolio

            22.3.1.3. Profitability by Market Segments (Product/Region)

            22.3.1.4. Sales Footprint

            22.3.1.5. Strategy Overview

        22.3.2. Sanofi

            22.3.2.1. Overview

            22.3.2.2. Product Portfolio

            22.3.2.3. Profitability by Market Segments (Product/Region)

            22.3.2.4. Sales Footprint

            22.3.2.5. Strategy Overview

        22.3.3. AstraZeneca

            22.3.3.1. Overview

            22.3.3.2. Product Portfolio

            22.3.3.3. Profitability by Market Segments (Product/Region)

            22.3.3.4. Sales Footprint

            22.3.3.5. Strategy Overview

        22.3.4. Merck & Co., Inc.

            22.3.4.1. Overview

            22.3.4.2. Product Portfolio

            22.3.4.3. Profitability by Market Segments (Product/Region)

            22.3.4.4. Sales Footprint

            22.3.4.5. Strategy Overview

        22.3.5. GlaxoSmithKline plc

            22.3.5.1. Overview

            22.3.5.2. Product Portfolio

            22.3.5.3. Profitability by Market Segments (Product/Region)

            22.3.5.4. Sales Footprint

            22.3.5.5. Strategy Overview

        22.3.6. Serum Institute of India Pvt. Ltd.

            22.3.6.1. Overview

            22.3.6.2. Product Portfolio

            22.3.6.3. Profitability by Market Segments (Product/Region)

            22.3.6.4. Sales Footprint

            22.3.6.5. Strategy Overview

        22.3.7. Bharat Biotech

            22.3.7.1. Overview

            22.3.7.2. Product Portfolio

            22.3.7.3. Profitability by Market Segments (Product/Region)

            22.3.7.4. Sales Footprint

            22.3.7.5. Strategy Overview

        22.3.8. Sinovac Biotech Ltd.

            22.3.8.1. Overview

            22.3.8.2. Product Portfolio

            22.3.8.3. Profitability by Market Segments (Product/Region)

            22.3.8.4. Sales Footprint

            22.3.8.5. Strategy Overview

23. Assumptions and Acronyms Used

24. Research Methodology

Know More Details About the Report

List of Tables

Table 01 Pipeline Analysis (1/4)

Table 02 Pipeline Analysis (2/4)

Table 03 Pipeline Analysis (3/4)

Table 04 Pipeline Analysis (4/4)

Table 05 Key Industry Events (Mergers, Acquisitions, Collaborations, Approvals, etc.) (1/3)

Table 06 Key Industry Events (Mergers, Acquisitions, Collaborations, Approvals, etc.) (2/3)

Table 07 Key Industry Events (Mergers, Acquisitions, Collaborations, Approvals, etc.) (3/3)

Table 08 Global Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 09 Global Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 10 Global Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Indication, 2018–2030

Table 11 Global Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Age Group, 2018–2030

Table 12 Global Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 13 Global Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 14 North America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 15 North America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 16 North America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 17 North America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Indication, 2018–2030

Table 18 North America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Age Group, 2018–2030

Table 19 North America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 20 Europe Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 21 Europe Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 22 Europe Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 23 Europe Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Indication, 2018–2030

Table 24 Europe Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Age Group, 2018–2030

Table 25 Europe Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 26 Asia Pacific Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 27 Asia Pacific Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 28 Asia Pacific Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 29 Asia Pacific Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Indication, 2018–2030

Table 30 Asia Pacific Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Age Group, 2018–2030

Table 31 Asia Pacific Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 32 Latin America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 33 Latin America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 34 Latin America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 35 Latin America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Indication, 2018–2030

Table 36 Latin America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Age Group, 2018–2030

Table 37 Latin America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 38 Middle East & Africa Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 39 Middle East & Africa Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 40 Middle East & Africa Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 41 Middle East & Africa Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Indication, 2018–2030

Table 42 Middle East & Africa Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by Age Group, 2018–2030

Table 43 Middle East & Africa Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Have a report related query? Speak to us directly

List of Figures

Figure 01 Global Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, 2018–2030

Figure 02 Global Respiratory Virus Vaccines Market Value Share Analysis, by Type, 2019 and 2030

Figure 03 Global Respiratory Virus Vaccines Market Attractiveness Analysis, by Type, 2020–2030

Figure 04 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Inactivated/Killed Vaccines, 2018–2030 

Figure 05 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Live-attenuated Vaccines, 2018–2030 

Figure 06 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Recombinant vaccines, 2018–2030 

Figure 07 Global Respiratory Virus Vaccines Market Value Share Analysis, by Route of Administration, 2019 and 2030

Figure 08 Global Respiratory Virus Vaccines Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 09 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Intramuscular, 2018–2030 

Figure 10 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Intranasal, 2018–2030 

Figure 11 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Subcutaneous, 2018–2030 

Figure 12 Global Respiratory Virus Vaccines Market Value Share Analysis, by Indication, 2019 and 2030

Figure 13 Global Respiratory Virus Vaccines Market Attractiveness Analysis, by Indication, 2020–2030

Figure 14 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Influenza, 2018–2030 

Figure 15 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Measles, Mumps & Rubella, 2018–2030 

Figure 16 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Coronavirus Disease (COVID-19), 2018–2030 

Figure 17 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2018–2030 

Figure 18 Global Respiratory Virus Vaccines Market Value Share Analysis, by Age Group, 2019 and 2030

Figure 19 Global Respiratory Virus Vaccines Market Attractiveness Analysis, by Age Group, 2020–2030

Figure 20 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Pediatric, 2018–2030 

Figure 21 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Adult, 2018–2030 

Figure 22 Global Respiratory Virus Vaccines Market Value Share Analysis, by End-user, 2019 and 2030

Figure 23 Global Respiratory Virus Vaccines Market Attractiveness Analysis, by End-user, 2020–2030

Figure 24 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Physician Offices, 2018–2030 

Figure 25 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2018–2030 

Figure 26 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Clinics, 2018–2030 

Figure 27 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Pharmacy/Store, 2018–2030 

Figure 28 Global Respiratory Virus Vaccines Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2018–2030 

Figure 29 Global Respiratory Virus Vaccines Market Value Share Analysis, by Region, 2019 and 2030

Figure 30 Global Respiratory Virus Vaccines Market Attractiveness Analysis, by Region, 2020–2030

Figure 31 North America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, 2018–2030

Figure 32 North America Respiratory Virus Vaccines Market Value Share Analysis, by Country, 2019 and 2030

Figure 33 North America Respiratory Virus Vaccines Market Attractiveness Analysis, by Country, 2020–2030

Figure 34 North America Respiratory Virus Vaccines Market Value Share Analysis, by Type, 2019 and 2030

Figure 35 North America Respiratory Virus Vaccines Market Attractiveness Analysis, by Type, 2020–2030

Figure 36 North America Respiratory Virus Vaccines Market Value Share Analysis, by Route of Administration, 2019 and 2030

Figure 37 North America Respiratory Virus Vaccines Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 38 North America Respiratory Virus Vaccines Market Value Share Analysis, by Indication, 2019 and 2030

Figure 39 North America Respiratory Virus Vaccines Market Attractiveness Analysis, by Indication, 2020–2030

Figure 40 North America Respiratory Virus Vaccines Market Value Share Analysis, by Age Group, 2019 and 2030

Figure 41 North America Respiratory Virus Vaccines Market Attractiveness Analysis, by Age Group, 2020–2030

Figure 42 North America Respiratory Virus Vaccines Market Value Share Analysis, by End-user, 2019 and 2030

Figure 43 North America Respiratory Virus Vaccines Market Attractiveness Analysis, by End-user, 2020–2030

Figure 44 Europe Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, 2018–2030

Figure 45 Europe Respiratory Virus Vaccines Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 46 Europe Respiratory Virus Vaccines Market Attractiveness Analysis, by Country, 2020–2030

Figure 47 Europe Respiratory Virus Vaccines Market Value Share Analysis, by Type, 2019 and 2030

Figure 48 Europe Respiratory Virus Vaccines Market Attractiveness Analysis, by Type, 2020–2030

Figure 49 Europe Respiratory Virus Vaccines Market Value Share Analysis, by Route of Administration, 2019 and 2030

Figure 50 Europe Respiratory Virus Vaccines Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 51 Europe Respiratory Virus Vaccines Market Value Share Analysis, by Indication, 2019 and 2030

Figure 52 Europe Respiratory Virus Vaccines Market Attractiveness Analysis, by Indication, 2020–2030

Figure 53 Europe Respiratory Virus Vaccines Market Value Share Analysis, by Age Group, 2019 and 2030

Figure 54 Europe Respiratory Virus Vaccines Market Attractiveness Analysis, by Age Group, 2020–2030

Figure 55 Europe Respiratory Virus Vaccines Market Value Share Analysis, by End-user, 2019 and 2030

Figure 56 Europe Respiratory Virus Vaccines Market Attractiveness Analysis, by End-user, 2020–2030

Figure 57 Asia Pacific Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, 2018–2030

Figure 58 Asia Pacific Respiratory Virus Vaccines Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 59 Asia Pacific Respiratory Virus Vaccines Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 60 Asia Pacific Respiratory Virus Vaccines Market Value Share Analysis, by Type, 2019 and 2030

Figure 61 Asia Pacific Respiratory Virus Vaccines Market Attractiveness Analysis, by Type, 2020–2030

Figure 62 Asia Pacific Respiratory Virus Vaccines Market Value Share Analysis, by Route of Administration, 2019 and 2030

Figure 63 Asia Pacific Respiratory Virus Vaccines Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 64 Asia Pacific Respiratory Virus Vaccines Market Value Share Analysis, by Indication, 2019 and 2030

Figure 65 Asia Pacific Respiratory Virus Vaccines Market Attractiveness Analysis, by Indication, 2020–2030

Figure 66 Asia Pacific Respiratory Virus Vaccines Market Value Share Analysis, by Age Group, 2019 and 2030

Figure 67 Asia Pacific Respiratory Virus Vaccines Market Attractiveness Analysis, by Age Group, 2020–2030

Figure 68 Asia Pacific Respiratory Virus Vaccines Market Value Share Analysis, by End-user, 2019 and 2030

Figure 69 Asia Pacific Respiratory Virus Vaccines Market Attractiveness Analysis, by End-user, 2020–2030

Figure 70 Latin America Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, 2018–2030

Figure 71 Latin America Respiratory Virus Vaccines Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 72 Latin America Respiratory Virus Vaccines Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 73 Latin America Respiratory Virus Vaccines Market Value Share Analysis, by Type, 2019 and 2030

Figure 74 Latin America Respiratory Virus Vaccines Market Attractiveness Analysis, by Type, 2020–2030

Figure 75 Latin America Respiratory Virus Vaccines Market Value Share Analysis, by Route of Administration, 2019 and 2030

Figure 76 Latin America Respiratory Virus Vaccines Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 77 Latin America Respiratory Virus Vaccines Market Value Share Analysis, by Indication, 2019 and 2030

Figure 78 Latin America Respiratory Virus Vaccines Market Attractiveness Analysis, by Indication, 2020–2030

Figure 79 Latin America Respiratory Virus Vaccines Market Value Share Analysis, by Age Group, 2019 and 2030

Figure 80 Latin America Respiratory Virus Vaccines Market Attractiveness Analysis, by Age Group, 2020–2030

Figure 81 Latin America Respiratory Virus Vaccines Market Value Share Analysis, by End-user, 2019 and 2030

Figure 82 Latin America Respiratory Virus Vaccines Market Attractiveness Analysis, by End-user, 2020–2030

Figure 83 Middle East & Africa Respiratory Virus Vaccines Market Value (US$ Mn) Forecast, 2018–2030

Figure 84 Middle East & Africa Respiratory Virus Vaccines Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 85 Middle East & Africa Respiratory Virus Vaccines Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 86 Middle East & Africa Respiratory Virus Vaccines Market Value Share Analysis, by Type, 2019 and 2030

Figure 87 Middle East & Africa Respiratory Virus Vaccines Market Attractiveness Analysis, by Type, 2020–2030

Figure 88 Middle East & Africa Respiratory Virus Vaccines Market Value Share Analysis, by Route of Administration, 2019 and 2030

Figure 89 Middle East & Africa Respiratory Virus Vaccines Market Attractiveness Analysis, by Route of Administration, 2020–2030

Figure 90 Middle East & Africa Respiratory Virus Vaccines Market Value Share Analysis, by Indication, 2019 and 2030

Figure 91 Middle East & Africa Respiratory Virus Vaccines Market Attractiveness Analysis, by Indication, 2020–2030

Figure 92 Middle East & Africa Respiratory Virus Vaccines Market Value Share Analysis, by Age Group, 2019 and 2030

Figure 93 Middle East & Africa Respiratory Virus Vaccines Market Attractiveness Analysis, by Age Group, 2020–2030

Figure 94 Middle East & Africa Respiratory Virus Vaccines Market Value Share Analysis, by End-user, 2019 and 2030

Figure 95 Middle East & Africa Respiratory Virus Vaccines Market Attractiveness Analysis, by End-user, 2020–2030

Respiratory Virus Vaccines Market - Scope of the Report

A recent study by Fact.MR on the respiratory virus vaccines market offers a 10-year forecast for 2020 and 2030. The study analyzes crucial trends that are currently determining the growth of the respiratory virus vaccines market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with the manufacturing of respiratory virus vaccines.

The study also provides the dynamics that are responsible for influencing the future status of the respiratory virus vaccines market over the forecast period.

A detailed assessment of respiratory virus vaccines value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

A list of prominent companies operating in the respiratory virus vaccines market along with their product portfolios enhances the reliability of this comprehensive research study.

Respiratory Virus Vaccines Market: Report Summary

The study offers a comprehensive analysis on diverse features, including demand, product developments, revenue generation, and sales in the respiratory virus vaccines market across the globe.

A comprehensive estimate on the respiratory virus vaccines market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of respiratory virus vaccines during the forecast period. Price point comparison by region with global average price is also considered in the study.

Respiratory Virus Vaccines Market: Analysis on Market Size Evaluation

The respiratory virus vaccines market has been analyzed for each market segment in terms of value (US$ Mn).

Market estimates at global and regional levels for respiratory virus vaccines are available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent respiratory virus vaccines market segments, along with market attractiveness evaluation, has been incorporated in the report.

Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report. Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global respiratory virus vaccines market.

Respiratory Virus Vaccines Market: Inspected Assessment on Regional Segments

Key sections have been elaborated in the respiratory virus vaccines market report, which have helped deliver projections on regional markets.

These chapters include regional macros (political economic and business environment outlook), which are expected to have a momentous influence on the growth of the respiratory virus vaccines market during the forecast period.

Country-specific valuation on demand for respiratory virus vaccines has been offered for each regional market, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value and volume for emerging countries has also been included in the report.

Respiratory Virus Vaccines Market: In-depth Analysis on Competitive Landscape

The report sheds light on the leading manufacturers of respiratory virus vaccines, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in the production of respiratory virus vaccines has been brought with the help of a detailed dashboard view.

Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

- FAQs -

Respiratory virus vaccines market is forecast to rise at a CAGR of over 7% from 2020 and 2030.
The respiratory virus vaccines market size to surpass US$ 14 Bn valuation by 2030.
Inactive/ killed vaccines currently accounts for a leading market share.

Need an Exclusive Report for your Unique Requirement?

- Related Reports -

Natural Gelling Agents Market

Natural Gelling Agents Market is forecast to reach a valuation of US$ 6.33 Bn by 2032. Gelatin as a ...

Natural Cheese Market

Natural Cheese Market to reach a valuation of US$ 8 Billion by the end of the year 2022. Goat milk b...

Natural Skin Care Products Market

The global natural skin care product market is anticipated to secure a market value of USD 13.4 Bn b...

Natural Cold, Cough, and Sore Throat Remedies Market

[170 Pages Report] Natural Cold, Cough, and Sore Throat Remedies Market research report categorizes ...

- Our Clients -

Report Client

- Evaluate How Fact.MR's Report Can Help. -

Is the market research conducted by Fact.MR?

Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.

What research methodology is followed by Fact.MR?

Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.

What are the sources of secondary research?

Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.

Who are the respondents for primary research?

Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.

Is a sample of this report available for evaluation?

Yes, you can request a sample, and it will be sent to you through an email.